Literature DB >> 8164617

The importance of the highest normokalemia in the treatment of early hepatic encephalopathy.

G Zavagli1, G Ricci, G Bader, G Mapelli, F Tomasi, B Maraschin.   

Abstract

An inverse relation is known to link blood potassium with renal synthesis and the release of ammonia. Given the liability of hyperammonemia for precipitating hepatic encephalopathy (HE), 28 patients affected by stage I HE were equally divided into two groups and maintained up to their death at the highest (5.4-5.5 mEq/l) or the lowest (3.5-3.6 mEq/l) normokalemia levels. When compared with the lowest normokalemia group, the highest one showed an early, albeit transient, improvement in the mental state (as assessed by both EEG and psychiatric investigations) and to a lesser extent in hepatic functions (as assessed by the variations in serum bilirubin, GPT, GGT and plasma prothrombin time). In the highest normokalemia group the survival was also prolonged. The cause of this improvement may be related to the induced decrease in blood pH, the consequent depression of renal ammoniagenesis and the rise in the arterial and urine NH+4/NH3 ratios. These factors reduce the entry of ammonia into the cells and enhance the urinary excretion of this metabolite, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8164617

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  3 in total

1.  Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist.

Authors:  R Todd Stravitz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

2.  Resolution of neurologic signs presumed to be associated with hyperammonemia in 2 endurance horses.

Authors:  C Langdon Fielding; K Gary Magdesian; Jennifer R Mayer
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

3.  Incisional hernia as an unusual cause of hepatic encephalopathy in a 62-year-old man with cirrhosis: a case report.

Authors:  Muge Ustaoglu; Tulay Bakir; Ahmet Bektas; Osman Cure; Bulent Gungor
Journal:  J Med Case Rep       Date:  2009-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.